• Projet
    • A propos du projet
    • Workpackages
    • Comité scientifique consultatif
  • Consortium
    • Partenaires académiques
    • Partenaires industriels
  • Résultats
    • Publications
    • Actualités
  • Contact
  • Français
    • English
    • Français

  • Projet
    • A propos du projet
    • Workpackages
    • Comité scientifique consultatif
  • Consortium
    • Partenaires académiques
    • Partenaires industriels
  • Résultats
    • Publications
    • Actualités
  • Contact
  • Français
    • English
    • Français
RésultatsPublications

Publications

Publications 25 septembre 2023

Blockade of interferon signaling decreases gut barrier integrity and promotes severe West Nile virus disease.

The determinants of severe disease caused by West Nile virus (WNV) and why only ~1% of individuals progress to encephalitis remain poorly understood. Here, we use human and mouse enteroids, and a mouse model of pathogenesis, to explore the capacity [...]

Lire la suite

Publications 4 septembre 2023

Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients.

Mosquito-borne West Nile virus (WNV) infection is benign in most individuals but can cause encephalitis in <1% of infected individuals. We show that ∼35% of patients hospitalized for WNV disease (WNVD) in six independent cohorts from the EU and USA [...]

Lire la suite

Publications 1 septembre 2023

Dissecting human population variation in single-cell responses to SARS-CoV-2.

Humans display substantial interindividual clinical variability after SARS-CoV-2 infection, the genetic and immunological basis of which has begun to be deciphered. However, the extent and drivers of population differences in immune responses to SARS-CoV-2 remain unclear. Here we report single-cell [...]

Lire la suite

Publications 1 septembre 2023

Intestinal Candida albicans overgrowth in IgA deficiency.

Secretory IgA interacts with commensal bacteria, but its impact on human mycobiota ecology has not been widely explored. In particular, whether human IgA-deficiency is associated with gut fungal dysbiosis remains unknown. Our goal was to study the impact of IgA on [...]

Lire la suite

Publications 10 août 2023

Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants.

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is silent or benign in most infected individuals, but causes hypoxemic COVID-19 pneumonia in about 10% of cases. We review studies of the human genetics of life-threatening COVID-19 pneumonia, focusing on both [...]

Lire la suite

Publications 1 août 2023

Human genetic and immunological determinants of SARS-CoV-2 and Epstein-Barr virus diseases in childhood: Insightful contrasts.

There is growing evidence to suggest that severe disease in children infected with common viruses that are typically benign in other children can result from inborn errors of immunity or their phenocopies. Infection with severe acute respiratory syndrome coronavirus 2 [...]

Lire la suite

Publications 1 août 2023

Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia.

Autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) are found in the blood of at least 15% of unvaccinated patients with life-threatening COVID-19 pneumonia. We report here the presence of auto-Abs neutralizing type I IFNs in the bronchoalveolar lavage (BAL) of [...]

Lire la suite

Publications 1 mai 2023

Ancient DNA as a tool for medical research.

No abstract availableDOI: 10.1038/s41591-023-02244-4, PMID: 36922577Authors: Gaspard Kerner, Jeremy Choin, Lluis Quintana-Murci

Lire la suite

Publications 5 avril 2023

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.

We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15-20% of cases of life-threatening COVID-19 in unvaccinated patients. [...]

Lire la suite

Publications 1 avril 2023

Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children.

Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/coronavirus disease 2019 (COVID-19) pandemic, global sequencing efforts have led in the field of inborn errors of immunity, and inspired particularly by previous research on life-threatening influenza, they have [...]

Lire la suite

  • Projet
    • A propos du projet
    • Workpackages
    • Comité scientifique consultatif
  • Consortium
    • Partenaires académiques
    • Partenaires industriels
  • Résultats
    • Publications
    • Actualités
  • Contact
  • Français
    • English
    • Français
Institut Imagine
24 Boulevard du Montparnasse 75015 Paris France
  • Projet
  • Consortium
  • Mentions légales
  • Contact
Tous droits réservés © RHU COVIFERON 2026